• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cisco Issues Weak Outlook, Joins Fastly, Herbalife And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

    2/15/24 5:30:10 AM ET
    $ALB
    $CSCO
    $ENGN
    $FSLY
    Major Chemicals
    Industrials
    Computer Communications Equipment
    Telecommunications
    Get the next $ALB alert in real time by email

    U.S. stock futures were higher this morning, with the Dow futures trading higher by around 70 points on Thursday.

    Shares of Cisco Systems, Inc. (NASDAQ:CSCO) fell in today’s pre-market trading following second-quarter results.

    Cisco reported better-than-expected second-quarter financial results but issued weak full-year 2024 guidance. The company also announced a restructuring plan to cut approximately 5% of its global workforce.

    Cisco Systems shares fell 5.2% to $47.68 in pre-market trading.

    Here are some big stocks recording losses in today’s pre-market trading session.

    • Nu Skin Enterprises, Inc. (NYSE:NUS) shares dipped 24% to $13.25 in pre-market trading after the company reported fourth-quarter financial results.
    • Fastly, Inc. (NYSE:FSLY) shares fell 23.1% to $18.10 in pre-market trading after the company reported mixed fourth-quarter financial results.
    • enGene Holdings Inc. (NASDAQ:ENGN) shares declined 13.3% to $14.30 in pre-market trading. enGene shares jumped around 116% on Wednesday after the company announced an oversubscribed $200 million private placement financing.
    • Herbalife Ltd. (NYSE:HLF) shares fell 12.3% to $10.30 in pre-market trading following weak quarterly earnings.
    • Twilio Inc. (NYSE:TWLO) fell 12.1% to $63.51 in pre-market trading after the company reported fourth-quarter financial results.
    • Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) tumbled 10.7% to $10.64 in pre-market trading after jumping around 70% on Wednesday.
    • Larimar Therapeutics, Inc. (NASDAQ:LRMR) fell 7.9% to $11.01 in pre-market trading after gaining over 36% on Wednesday. Larimar Therapeutics priced the public offering of 17.16 million shares at $8.74/share for gross proceeds of approximately $150 million.
    • Rollins, Inc. (NYSE:ROL) fell 6.3% to $41.48 in pre-market trading following quarterly results.
    • Albemarle Corporation (NYSE:ALB) shares fell 5.6% to $108.00 in pre-market trading following quarterly results.

     

    Now Read This: Investor Sentiment Improves; Dow Jumps Over 150 Points

    Don’t forget to check out our premarket coverage here

    Get the next $ALB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB
    $CSCO
    $ENGN
    $FSLY

    CompanyDatePrice TargetRatingAnalyst
    Cisco Systems Inc.
    $CSCO
    2/18/2026Buy → Hold
    Erste Group
    Albemarle Corporation
    $ALB
    2/17/2026$190.00Neutral → Buy
    BofA Securities
    Rollins Inc.
    $ROL
    2/17/2026$67.00Buy
    BofA Securities
    Rollins Inc.
    $ROL
    2/12/2026$56.00Overweight → Equal Weight
    Wells Fargo
    Fastly Inc.
    $FSLY
    2/12/2026Mkt Perform → Outperform
    William Blair
    enGene Holdings Inc.
    $ENGN
    1/30/2026$28.00Buy
    Jefferies
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    Albemarle Corporation
    $ALB
    1/21/2026$205.00Hold → Buy
    Truist
    More analyst ratings

    $ALB
    $CSCO
    $ENGN
    $FSLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cisco downgraded by Erste Group

    Erste Group downgraded Cisco from Buy to Hold

    2/18/26 9:41:39 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Albemarle upgraded by BofA Securities with a new price target

    BofA Securities upgraded Albemarle from Neutral to Buy and set a new price target of $190.00

    2/17/26 8:01:23 AM ET
    $ALB
    Major Chemicals
    Industrials

    BofA Securities resumed coverage on Rollins with a new price target

    BofA Securities resumed coverage of Rollins with a rating of Buy and set a new price target of $67.00

    2/17/26 7:30:15 AM ET
    $ROL
    Diversified Commercial Services
    Consumer Discretionary

    $ALB
    $CSCO
    $ENGN
    $FSLY
    SEC Filings

    View All

    SEC Form 144 filed by Fastly Inc.

    144 - Fastly, Inc. (0001517413) (Subject)

    2/19/26 4:27:51 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    SEC Form S-3 filed by enGene Holdings Inc.

    S-3 - enGene Holdings Inc. (0001980845) (Filer)

    2/19/26 4:25:39 PM ET
    $ENGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form 10-K/A filed by enGene Holdings Inc.

    10-K/A - enGene Holdings Inc. (0001980845) (Filer)

    2/19/26 4:15:02 PM ET
    $ENGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALB
    $CSCO
    $ENGN
    $FSLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Product Officer Hatchett Steven Keith bought $52,855 worth of shares (5,500 units at $9.61), increasing direct ownership by 3% to 167,565 units (SEC Form 4)

    4 - NU SKIN ENTERPRISES, INC. (0001021561) (Issuer)

    11/12/25 4:32:45 PM ET
    $NUS
    Other Pharmaceuticals
    Health Care

    * Director by Deputization Flynn James E bought $30,000,000 worth of shares (9,375,000 units at $3.20) (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    8/4/25 6:28:33 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALB
    $CSCO
    $ENGN
    $FSLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Bergman Artur sold $1,448,203 worth of shares (74,457 units at $19.45), decreasing direct ownership by 2% to 1,842,532 units (SEC Form 4)

    4 - Fastly, Inc. (0001517413) (Issuer)

    2/23/26 4:55:18 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    CEO Compton Charles Lacey Iii sold $279,402 worth of shares (14,797 units at $18.88), decreasing direct ownership by 2% to 584,519 units (SEC Form 4)

    4 - Fastly, Inc. (0001517413) (Issuer)

    2/23/26 4:55:23 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    Chief Commercial Officer Norris Eric sold $941,741 worth of shares (5,692 units at $165.45), decreasing direct ownership by 10% to 48,819 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    2/23/26 4:33:24 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    $CSCO
    $ENGN
    $FSLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Herbalife Plans to Refinance Senior Secured Debt

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced plans to refinance its senior secured debt. The Company is targeting $1.55 billion of secured financing, which is expected to include a $425 million revolving credit facility, a $125 million Term Loan A, a $500 million Term Loan B and $500 million of other secured debt. The refinancing is also expected to extend the maturity profile of the senior secured debt. Today, the Company initiated the refinancing process for its Term Loan B, which matures in April 2029. As of December 31, 2025, $370.0 million was outstanding under the Term Loan B. The terms of the proposed refinancing transa

    2/23/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Sharon AI & Cisco Launch Australia's First Cisco Secure AI Factory with NVIDIA

    News summary Cisco and Sharon AI launch Australia's first Cisco Secure AI Factory with NVIDIA, providing secure, high-performance AI infrastructure with all data processing remaining in the country. Powered by 1024 NVIDIA Blackwell Ultra GPUs, Cisco's UCS servers and Nexus Hyperfabric technology, it supports Australia's National AI Plan and accelerates enterprise AI adoption and innovation across the Asia-Pacific region. This initiative positions Australia to lead in sovereign and responsible AI, empowering enterprises to develop advanced AI solutions while maintaining the highest security standards. Today, Cisco (NASDAQ:CSCO) and SharonAI Holdings Inc. (NASDAQ:SHAZ) and its sub

    2/23/26 12:15:00 AM ET
    $CSCO
    $SHAZ
    Computer Communications Equipment
    Telecommunications
    EDP Services
    Technology

    NYSE Content Update: Starfighters Space Celebrates NYSE American Listing

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 20, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 20thInvestors digest a pair of key reports from the U.S. Bureau of Economic Analysis, including the December PCE Report, the Fed's preferred inflation gauge.Herbalife (NYSE:HLF) CFO John DeSimone will join NYSE Live to discuss the nutrition company's latest earnings and a new $7.5 million investment by soccer legend

    2/20/26 8:55:00 AM ET
    $FJET
    $HLF
    $ICE
    Air Freight/Delivery Services
    Consumer Discretionary
    Other Pharmaceuticals
    Health Care

    $ALB
    $CSCO
    $ENGN
    $FSLY
    Financials

    Live finance-specific insights

    View All

    Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA1 Exceed Guidance

    Cristiano Ronaldo Invests $7.5 Million in Herbalife's Pro2col™ Technology Herbalife Ltd. (NYSE:HLF) today reported financial results for the fourth quarter and year ended December 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218518159/en/ "We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo's investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions." - Stephan Gratziani, CEO Hi

    2/18/26 4:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Announces Cristiano Ronaldo Invests $7.5 Million in Pro2col™ Technology, Acquires 10% Equity Stake

    Long-time partner invests in shared vision for personalized health and wellness Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced global sports icon Cristiano Ronaldo acquired a 10% equity interest in HBL Pro2col Software, LLC, an indirect wholly-owned subsidiary of Herbalife that holds the Pro2col technology. Pro2col is Herbalife's next-generation, digital, personalized health and wellness operating system, designed to drive daily engagement, sustainable behavior change, and measurable outcomes through a structured, data-driven approach to wellness. This press release features multimedia. View the full release here: https://www.bus

    2/18/26 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance

    Company provides initial outlook for Q1 and fiscal year 2026, forecasting a return to revenue growth by year's end Nu Skin Enterprises Inc. (NYSE:NUS) today announced fourth quarter and full-year 2025 revenue and earnings within guidance with more than 50% growth in earnings for 2025. Executive Summary Q4 2025 vs. Prior-year Quarter Revenue $370.3 million; (16.9)% or (10.4)% excluding Mavely 2024 revenue (0.2)% FX impact or $(0.8) million Earnings Per Share (EPS) $0.29 compared to $(0.73) or $0.38 excluding restructuring and other charges Customers 748,796; (10)% Paid Affiliates 129,311; (11)% Sales Leaders 30,045; (

    2/12/26 4:06:00 PM ET
    $NUS
    Other Pharmaceuticals
    Health Care

    $ALB
    $CSCO
    $ENGN
    $FSLY
    Leadership Updates

    Live Leadership Updates

    View All

    Fastly Announces Listing Transfer to Nasdaq

    Ticker symbol to remain "FSLY" Fastly, Inc. (NYSE:FSLY), a leader in global edge cloud platforms, announced today that it will voluntarily transfer its stock exchange listing from the New York Stock Exchange ("NYSE") to the Nasdaq Global Select Market ("Nasdaq"). Fastly expects to begin trading as a Nasdaq-listed company on or about December 9, 2025, and will continue to trade under its current ticker symbol "FSLY". "We're excited to join Nasdaq and be listed among the most innovative and leading technology companies in the world," said Kip Compton, CEO at Fastly. "This is one of several steps in our current transformation as we scale Fastly while working to unlock long-term value for cus

    11/26/25 8:00:00 AM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    enGene Appoints Hussein Sweiti, M.D., MSc, as Chief Medical Officer

    Bladder cancer development leader who helped drive recent FDA product approval in NMIBC joins to lead research and development strategy Appointment strengthens enGene's clinical development and regulatory capabilities ahead of planned 2H 2026 BLA submission for detalimogene enGene Holdings Inc. (NASDAQ:ENGN, "enGene" or the "Company")), a clinical-stage, non-viral genetic medicine company, today announced that Hussein Sweiti, M.D., MSc, was appointed Chief Medical Officer, effective September 29, 2025. Dr. Sweiti is a surgical oncologist and physician-scientist with more than 15 years of experience spanning clinical practice, oncology clinical research, global drug development, regula

    9/30/25 7:30:00 AM ET
    $ENGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    $ALB
    $CSCO
    $ENGN
    $FSLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by enGene Holdings Inc.

    SC 13G/A - enGene Holdings Inc. (0001980845) (Subject)

    11/14/24 5:48:15 PM ET
    $ENGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by enGene Holdings Inc.

    SC 13G/A - enGene Holdings Inc. (0001980845) (Subject)

    11/14/24 5:05:21 PM ET
    $ENGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care